The 20 Best Movement Disorders Doctors Near Me in Ann Arbor, MI

Nicolaas Bohnen is a Neurologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Bohnen is rated as an Elite provider by MediFind in the treatment of Movement Disorders. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Osteopenia, Melorheostosis, and Deep Brain Stimulation.

Kirk Frey is a Neurologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Frey is rated as an Elite provider by MediFind in the treatment of Movement Disorders. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Neuroendocrine Tumor, Osteopenia, and Hormone Replacement Therapy (HRT).

Roger L. Albin, M.D. (Residency 1986), is a professor of neurology, associate chair for research and co-director of the Movement Disorders Clinic in the Department of Neurology in the University of Michigan Medical School. In addition, he serves as chief of neuroscience research at the VA Ann Arbor Healthcare System Geriatric Research Education and Clinical Center.Dr. Albin joined the U-M faculty in 1988 as an instructor in the Department of Neurology. He was promoted to assistant professor in 1989; associate professor in 1994; and achieved his current rank of full professor in 2000.After completing his undergraduate degree at Oberlin College in Ohio, Dr. Albin earned his medical degree from the University of Pittsburgh School of Medicine in 1982, and completed his residency at the University of Michigan in 1986. He also completed a movement disorders fellowship in 1988 under Drs. Anne Young and John Penney.His clinical and research interests include the underlying neurobiologic causes of the clinical features of movement disorders, basal ganglia structure and function, Parkinson's disease, Tourette syndrome, dementias, dystonias and Huntington's disease. His laboratory is pursuing work on basic mechanisms of neurodegeneration in Huntington disease using mouse genetic models. Dr. Albin also has participated in neuroprotective clinical trials for both Huntington's disease and Parkinson's disease.The present focus of Dr. Albin's group is uncovering the basis for non-motor (sleep disorders, depression, dementia, autonomic dysfunction) problems in Parkinson's disease. He is very interested in applying positron emission tomography (PET) imaging methods to improve diagnosis of dementing disorders like Alzheimer's disease. The hope is that understanding how specific brain alterations cause specific clinical features will lead to improved treatments.Dr. Albin currently serves as a site investigator for the National Institutes of Health (NIH) Exploratory Trials in Parkinson disease (NET-PD) initiative. His work is supported by grants from the NIH, the Michael J. Fox Foundation and the High Q Foundation.A member of the American Academy of Neurology, the American Association for the Advancement of Science, the American Neurologic Association, and the Society for Neuroscience, Dr. Albin currently serves on the editorial boards of Experimental Neurology, Neurology and Neurobiology of Disease. Dr. Albin is rated as an Elite provider by MediFind in the treatment of Movement Disorders. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Huntington Disease, Dementia, and Deep Brain Stimulation. Dr. Albin is board certified in Neurology.

Kelvin L. Chou, M.D. is a Clinical Professor in the Departments of Neurology and Neurosurgery at Michigan Medicine and was the inaugural Thomas H. and Susan C. Brown Early Career Professor in Neurology. Dr. Chou has been named to the Best Doctors of America list since 2011 and sees all patients with movement disorders (i.e. Parkinson’s disease, tremors, dystonia, Huntington disease), though he has a particular interest in Parkinson’s disease (PD) and deep brain stimulation (DBS). Dr. Chou serves as Co-Director of the STIM (Surgical Therapies Improving Movement) Program and his research focus is on improving the ability to treat movement disorders patients through DBS. He is also an experienced clinical trialist, conducting numerous clinical trials on new therapies for PD, essential tremor and Huntington disease. He directs the Neurology Clinical Trials Organization (NeCTO) and is Lead Medical Director of the Neuroscience and Sensory Clinical Trials Support Unit (CTSU) at Michigan Medicine. He has published over 100 peer-reviewed journal articles, review articles or book chapters on PD and related movement disorders. A strong patient advocate, Dr. Chou is the Education and Outreach Core Director for the U-M Udall Center of Excellence for PD Research and serves on the Professional Advisory Board of the Michigan Parkinson Foundation and the Medical Advisory Board of the International Essential Tremor Foundation (IETF). He has also authored a book for patients and families called Deep Brain Stimulation: A New Life for People with Parkinson's, Dystonia and Essential Tremor. Dr. Chou is rated as an Elite provider by MediFind in the treatment of Movement Disorders. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Essential Tremor, Drug Induced Dyskinesia, and Deep Brain Stimulation. Dr. Chou is board certified in Neurology.

Kara J. Wyant, MD, is a clinical lecturer in the Department of Neurology. She received her bachelor’s degrees in mathematics and music from Ohio Northern University, and medical degree from the University of Toledo College of Medicine. Dr. Wyant completed her neurology residency training at the University of Pittsburgh Medical Center, where she served as chief resident from 2015-2016. She is currently pursuing a fellowship in movement disorders at the University of Michigan focusing on the medical and surgical management of patients with Parkinson disease and parkinsonism. Dr. Wyant also serves on the neurohospitalist service at University Hospital, and participates in teleneurology consults for MidMichigan Health. Dr. (md) is rated as a Distinguished provider by MediFind in the treatment of Movement Disorders. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Drug Induced Dyskinesia, Parkinson's Disease, Movement Disorders, Dopa-Responsive Dystonia, and Deep Brain Stimulation. Dr. (md) is board certified in Neurology.

Dr. Kotagal completed residency training and a post-residency fellowship in Movement Disorders and Neurodegenerative diseases at the University of Michigan. He sees outpatients with Movement disorders including patients with Parkinson disease, atypical parkinsonian conditions, tremor, and gait impairments. He directs a subspecialty clinic for patients with suspected Normal Pressure Hydrocephalus. Dr. Kotagal is rated as a Distinguished provider by MediFind in the treatment of Movement Disorders. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Normal Pressure Hydrocephalus, Hydrocephalus, and Deep Brain Stimulation. Dr. Kotagal is board certified in Neurology.

Dr. Praveen Dayalu is an Associate Professor and the Thomas H. and Susan C. Brown Early Career Professor of Neurology at the University of Michigan. He graduated from medical school at Case Western Reserve University in Cleveland, in 2002, and then completed neurology residency and movement disorders fellowship at Michigan, in 2006. His main focus is clinical management of movement disorders, especially Parkinson disease. His research interests are in Huntington disease and Multiple System Atrophy. He is the Director of the Movement Disorders Fellowship and trains fellows, residents, and medical students. Dr. Dayalu is rated as a Distinguished provider by MediFind in the treatment of Movement Disorders. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Huntington Disease, Movement Disorders, Drug Induced Dyskinesia, and Parkinson's Disease. Dr. Dayalu is board certified in Neurology.

After graduating from Tehran University of Medical Sciences in 1990, Dr. Sohrab spent time in Spinal Cord Injury Centers of Iran, in multiple capacities, organizing care and educating different levels of practitioners in providing care for veterans of war. He then spent a few years of general practice, in different parts of Iran, dedicated to providing medical care and organizing Public Health Services, in rural areas. Dr. Sohrab has been practicing, and teaching, general Neurology at the University of Michigan, since 2012. Dr. Sohrab is rated as an Experienced provider by MediFind in the treatment of Movement Disorders. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Migraine, Vertigo, Migraine with Brainstem Aura, and Trigeminal Neuralgia.

Jack M. Parent, M.D., is a professor of neurology, director of the Neurodevelopment and Regeneration Laboratory, and co-director of the Comprehensive Epilepsy Center in the University of Michigan Medical School.His current research interests include neural stem cell transplantation to treat brain injury and neurodegeneration, and the modification of adult neural stem cells to promote brain repair after stroke or prevent epilepsy.Dr. Parent earned a Bachelor of Arts degree, with distinction, in human biology from Stanford University and his medical degree from the Yale University School of Medicine. He completed a medical internship and neurology residency at the University of California, San Francisco (UCSF), where he was selected chief resident. He stayed at UCSF for clinical fellowship training in epilepsy and clinical neurophysiology, and postdoctoral training in neuroscience research.An internationally recognized research leader in the fields of neural stem cell biology, regeneration after brain injury and epilepsy, Dr. Parent established the Neurodevelopment and Regeneration Laboratory at the U-M in 2000.Dr. Parent is a member of the Epilepsy Foundation of America Research Council, the Medical Advisory Board of the Global Ischemia Foundation, the Independent Science Review Panel of the New Jersey Commission on Brain Injury Research, and the National Scientific Advisory Council of the American Federation for Aging Research. He also serves as an associate editor of Neuroscience Letters, and is on the editorial boards of Experimental Neurology and Epilepsy Currents.He has received several awards for his research, including a Junior Investigator Award from the American Epilepsy Society, a Paul Beeson Physician Faculty Scholars in Aging Award, a Dreifuss-Penry Epilepsy Award from the American Academy of Neurology, and a Grass Foundation Award in Neuroscience from the American Neurological Association. Dr. Parent is rated as an Experienced provider by MediFind in the treatment of Movement Disorders. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Myoclonic Epilepsy, Epilepsy, Epilepsy with Myoclonic-Atonic Seizures, and Dravet Syndrome. Dr. Parent is board certified in Neurology and Clinical Neurophysiology.

Punithavathy Vijayakumar is a Neurologist and a Sleep Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Vijayakumar is rated as an Experienced provider by MediFind in the treatment of Movement Disorders. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Sclerosis (MS), Obstructive Sleep Apnea, Transient Ischemic Attack (TIA), and Migraine. Dr. Vijayakumar is board certified in Clinical Neurophysiology, Neurology, Neuromuscular Medicine, Sleep Medicine, and Vascular Neurology.

Vikram Shakkottai is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Shakkottai is rated as a Distinguished provider by MediFind in the treatment of Movement Disorders. He is also highly rated in 72 other conditions, according to our data. His clinical expertise encompasses Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, Spinocerebellar Ataxia Type 1, and Drug Induced Dyskinesia.

Henry L. Paulson, M.D., Ph.D., is the Lucile Groff Professor of Neurology for Alzheimer's Disease and Related Disorders in the Department of Neurology at the University of Michigan. Dr. Paulson joined the U-M faculty in 2007, and he currently directs the Michigan Alzheimer’s Disease Center (MADC) and co-direct the U-M Protein Folding Diseases Initiative.Dr. Paulson received his medical degree and doctorate in Cell Biology from Yale University in 1990. He then completed a neurology residency and neurogenetics/movement disorders fellowships at the University of Pennsylvania. In 1997, he joined the Neurology faculty at the University of Iowa, where he remained until 2007.Dr. Paulson's research and clinical interests concern the causes and treatment of age-related neurodegenerative diseases, with an emphasis on polyglutamine diseases, Alzheimer's disease and frontotemporal dementia. In 1997, his lab described abnormal protein aggregates in the polyglutamine diseases, which now are recognized as a pathological hallmark in this important class of inherited diseases. Using test tube, cell-based and animal models, he has contributed to advances in the understanding of various neurodegenerative diseases. His lab also has helped pioneer the use of gene silencing methods as potential therapy for the many neurological disorders caused by toxic mutant genes.Nationally, Dr. Paulson has directed popular courses at the American Academy of Neurology meetings, serves on the scientific advisory boards of numerous disease-related national organizations, and is past Chair of the Board of Scientific Counselors at the National Institute for Neurological Disorders and Stroke at the National Institutes of Health.Among his awards, Dr. Paulson is an Ellison Medical Foundation New Scholar in Aging, a semifinalist for the W.M. Keck Foundation Young Scholars in Medical Research, and a recipient of the Paul Beeson Physician Faculty Scholar in Aging Award from the American Federation for Aging Research. Dr. Paulson is rated as an Advanced provider by MediFind in the treatment of Movement Disorders. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia Type 3, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, and Drug Induced Dyskinesia. Dr. Paulson is board certified in Neurology.

Amelia Heston is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Heston is rated as an Advanced provider by MediFind in the treatment of Movement Disorders. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Parkinson's Disease, Movement Disorders, Chorea, Deep Brain Stimulation, and Thrombectomy. Dr. Heston is board certified in Neurology.

Daniel Leventhal, MD, PhD is an Assistant Professor of Neurology in the Movement Disorders division. His primary clinical duties are at the VA Ann Arbor Healthcare System, where he co-directs the Deep Brain Stimulation program for Movement Disorders. His practice there focuses on the treatment of Parkinson Disease, tremor disorders, dystonia, and related syndromes.Dr. Leventhal completed his undergraduate degree in Physics at The College of William and Mary in Virginia in 1995, and a combined MD/PhD program (PhD in Biomedical Engineering) at Case Western Reserve University in 2004. He then pursued medical internship and Neurology residency at the University of Michigan (completed in 2008), followed by a combined Movement Disorders and postdoctoral research fellowship at Michigan. In 2012, he joined the Neurology faculty at Michigan, and joined the VA as a staff Neurologist in 2015.Dr. Leventhal also directs a basic science laboratory at the University of Michigan. His research interests lie primarily in understanding the brain circuit abnormalities that contribute to the clinical manifestations of Parkinson Disease and related disorders. His laboratory uses advanced in vivo neuronal recordings and manipulations in rats and mice as they learn and perform complex behaviors.Dr. Leventhal is a member of the American Academy of Neurology, Movement Disorders Society, American Neurological Association, and Society for the Neural Control of Movement. Dr. Leventhal is rated as an Advanced provider by MediFind in the treatment of Movement Disorders. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Drug Induced Dyskinesia, Chorea, and Deep Brain Stimulation. Dr. Leventhal is board certified in Neurology.

Navid Seraji-Bozorgzad, MD, is an associate professor of neurology in the University of Michigan Medical School.Dr. Seraji-Bozorgzad began work in the area of medical imaging in 1990 as a research assistant during his undergraduate studies at the University of Michigan. He became familiar and developed a fundamental understanding of image acquisition and processing from his work on solid-state imaging arrays. After undergraduate work, he worked in the private sector as a software engineer, designing databases for various companies, including Ford Motor Company, and Liberty Mutual Insurance. The work provided him with experience in data-mining and manipulation of large datasets.His passion for medicine eventually led him to medical school. During the application process he worked in the Department of Psychiatry and Behavioral Neurosciences, and eventually enrolled in graduate school in neuroscience. While in the Department of Psychiatry, he participated in the use of various MR imaging techniques, including magnetic resonance spectroscopy and functional MRI for diagnosis and disease progression in mood disorders, including bipolar disorder. It was during his graduate studies that he developed an interest in the field of neurodegeneration, regeneration and neuroprotection.Dr. Seraji-Bozorgzad's research interest is primarily with non-invasive methods of monitoring disease progression in neurodegenerative disorders, with the ultimate goal of developing a tool set to monitor the efficacy of therapies early on in neurodegenerative disorders.His bibliography includes numerous peer-reviewed jornals and publications, abstracts and other media. Dr. Seraji is rated as an Advanced provider by MediFind in the treatment of Movement Disorders. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cerebellar Degeneration, Dementia, Vascular Dementia, and Alzheimer's Disease.

"Although he has lived in many places across the United States throughout childhood, Dr. Kevin Chen was born in the ""old"" Mott Children's Hospital at the University of Michigan. Dr. Chen completed his undergraduate degree (Neuroscience and Anthropology) at Johns Hopkins University, and his medical training at Duke University. This was followed by residency (Neurosurgery) at the University of Michigan and fellowship (Stereotactic/Functional Neurosurgery) at Stanford University.His clinical interests center on treating dysfunctional neural circuits, and using neuromodulation to help symptoms of movement disorders (e.g., Parkinson's disease, essential tremor, dystonia, etc.). Similarly, he has interest in neuromodulation using spinal cord stimulation for the treatment of certain chronic pain syndromes (e.g., complex regional pain syndrome, diabetic neuropathy, etc.), or use of intrathecal drug delivery (e.g., spasticity). He also has expertise in the surgical treatments of epilepsy, including vagal nerve stimulators, stereoelectroencephalography, responsive neurostimulators, deep brain stimulation for epilepsy, laser interstitial thermal therapy, and temporal lobectomy. During fellowship training, he also received training in the use of MRI-guided focused ultrasound, an incision-less approach for the treatment of movement disorders.Dr. Chen is an avid rock climber, and also enjoys swimming and snowboarding. He lives in Ann Arbor with his wife and daughter.". Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Movement Disorders. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Essential Tremor, Movement Disorders, Parkinson's Disease, Deep Brain Stimulation, and Microdiscectomy. Dr. Chen is board certified in Neurological Surgery.

Neena Marupudi is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Marupudi is rated as an Experienced provider by MediFind in the treatment of Movement Disorders. She is also highly rated in 53 other conditions, according to our data. Her clinical expertise encompasses Hydrocephalus, Tethered Cord Syndrome, Chiari Malformation Type 1, Rhizotomy, and Laminectomy. Dr. Marupudi is board certified in Neurological Surgery.

After completing his chief residency at the University of Virginia, Dr. Sagher accepted a position on the neurosurgical faculty at the University of Michigan. He became Chief of Neurosurgery at the Ann Arbor Veterans Administration Hospital, a position he held until 1996. He then completed a fellowship in Pain and Functional Neurosurgery at the Oregon Health Sciences University, and took over as the Director of Neuromodulation at the University of Michigan. As the primary functional neurosurgeon at the University of Michigan, Dr. Sagher takes care of such problems as epilepsy, pain, Parkinson's Disease and other movement disorders. Dr. Sagher is board certified by the American Board of Neurological Surgeons, and is a member of the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS). He has served on the Executive Council on the AANS/CNS Joint Section on Pain, which he chaired from 2003 to 2005. Special Interests: The treatment of epilepsy, pain, movement disorders, and brain tumors in functionally important regions. Dr. Sagher is rated as an Experienced provider by MediFind in the treatment of Movement Disorders. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Trigeminal Neuralgia, Meningioma, Seizures, Awake Craniotomy, and Microvascular Decompression. Dr. Sagher is board certified in Neurological Surgery.

Zach London, M.D. is a Professor in the University of Michigan Medical School. Dr. London grew up in Milwaukee, Wisconsin. He graduated Magna Cum Laude from Brown University in 1997. He attended medical school at the University of Wisconsin – Madison, graduating in 2001. He completed a Preliminary Medicine Internship at St. Joseph Mercy Hospital in Ann Arbor in 2001, followed by Neurology Residency at the University of Michigan. After graduation from residency, he did a one-year fellowship in Clinical Neurophysiology/EMG at the University of Michigan.He joined the University of Michigan faculty as a neuromuscular neurologist in 2006, and has served as Program Director of the neurology residency program. Dr. London’s scholarly focus is the development of interactive educational tools, with a focus on educational boardgames. He is the founder of Neurd Games, which includes popular titles such as The Lesion: Charcot’s Tournament, The Plexus, Endowed Chairs: Neurology, Formaina, and Field Cut. He also created EMG Whiz, a popular web-based EMG training simulator, and mobile applications to teach the tenets of neuroanatomic localization.He has published online learning modules for the American Academy of Neurology and other national organizations, in addition to traditional publishing research regarding medical education and electrodiagnostic studies.Dr. London has been recognized with numerous national teaching awards, including the American Academy of Neurology (AAN) A.B. Baker Lifetime Achievement Award in Neurologic Education in 2023, The American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Innovation Award in 2021, and the American Neurological Association (ANA) Distinguished Teacher Award in 2017. At the University of Michigan, he received the 2013 Silver Shovel Award, the Provost’s Teaching Innovation Prize in 2015, and, in 2017, the Kaiser Permanente Award. Departmental honors include the Status Pedagogicus Award in 2008, and the James Albers Collegiate Professorship in 2018. He has been an honorary member of the GALENS medical society most years since 2011. Dr. London regularly speaks at national meetings on topics of medical education, game development, and clinical neurophysiology. He has served as chair or member of committees and workgroups for the AAN, ANA, AANEM, and ACGME, including serving as the Chair of the Consortium of Neurology Program Directors.Outside his work, Zach London is a founding board member of the Penny Seats Theatre Company in Ann Arbor. He has also composed and released one original song every month since 1993, posting them on his personal website www.hardtaco.org. Dr. London is rated as an Experienced provider by MediFind in the treatment of Movement Disorders. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Peripheral Neuropathy, Chronic Inflammatory Demyelinating Polyneuropathy, and Chronic Polyradiculoneuritis. Dr. London is board certified in Neuromuscular Medicine, Neurology, and Electrodiagnostic Medicine.

Douglas J. Gelb, M.D., Ph.D., is a professor in the Department of Neurology in the University of Michigan Medical School. He is considered a national leader in neurologic education, and is part of a small group of investigators who have conducted research in the field. After earning a Bachelor of Arts in physics from Harvard College in 1977, Dr. Gelb completed his doctorate (1982) and medical degree (1984) at the Pritzker School of Medicine at the University of Chicago. He joined the U-M faculty after completing his neurology residency at the University of California, San Francisco in 1988. In 1992, Dr. Gelb became director of the third-year medical student neurology clerkship, and developed a syllabus that eventually evolved into a textbook. It is required or recommended by many neurology clerkships across the country, and it has been translated into two languages. In 2004, Dr. Gelb became director of a new second-year medical school course on diseases of the nervous system. In addition to his textbook, Dr. Gelb has developed a variety of educational materials, including a computer tutorial to teach the principles of neurologic localization. He has written examination questions and served on test-writing committees for the National Board of Medical Examiners Step 2 Examination and the NBME subject examination in neurology, the American Academy of Neurology (AAN) Resident Inservice Training Examination, and Continuum, a widely-used resource for continuing medical education produced by the AAN. He also has served as an examiner for the Oral Examination of the American Board of Psychiatry and Neurology (ABPN) on numerous occasions. Dr. Gelb is frequently honored by neurology residents, who have awarded him the Status Pedagogicus Award on four separate occasions. He has received numerous other awards for his teaching, including the Kaiser Permanente Award for Excellence in Teaching from the U-M, and the Distinguished Neurology Teacher Award from the American Neurological Association. He is a former chair of the national Consortium of Neurology Clerkship Directors, and of the American Academy of Neurology's A.B. Baker Section on Neurological Education. Dr. Gelb is rated as an Experienced provider by MediFind in the treatment of Movement Disorders. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Trigeminal Neuralgia, Migraine, Migraine with Brainstem Aura, and Seizures.